New Pill-and-Immunotherapy combo aims to shrink melanoma before surgery
Disease control
Not yet recruiting
This phase 2 trial tests whether adding an experimental immune-boosting pill (PRTX007) to standard immunotherapy (pembrolizumab) before surgery can improve outcomes for people with stage III melanoma. About 48 adults with resectable melanoma will take the combination for 9 weeks …
Phase: PHASE2 • Sponsor: Primmune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC